Lifecore Biomedical Inc (LFCR)
6.01
+0.14
(+2.30%)
USD |
NASDAQ |
Nov 04, 12:59
Lifecore Biomedical Debt to Equity Ratio: -32.48 for Aug. 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| August 31, 2024 | -32.48 |
| May 31, 2024 | 10.72 |
| February 29, 2024 | 6.617 |
| November 30, 2023 | 77.22 |
| August 31, 2023 | -7.959 |
| May 31, 2023 | -24.03 |
| February 28, 2023 | 3.361 |
| November 30, 2022 | 1.981 |
| August 31, 2022 | 1.471 |
| May 31, 2022 | 1.573 |
| February 28, 2022 | 0.8294 |
| November 30, 2021 | 1.064 |
| August 31, 2021 | 0.8038 |
| May 31, 2021 | 0.9562 |
| February 28, 2021 | 0.9092 |
| November 30, 2020 | 0.8145 |
| August 31, 2020 | 0.7865 |
| May 31, 2020 | 0.8237 |
| February 29, 2020 | 0.7056 |
| November 30, 2019 | 0.6975 |
| August 31, 2019 | 0.6233 |
| May 31, 2019 | 0.5515 |
| February 28, 2019 | 0.5311 |
| November 30, 2018 | 0.3227 |
| August 31, 2018 | 0.316 |
| Date | Value |
|---|---|
| May 31, 2018 | 0.2744 |
| February 28, 2018 | 0.2234 |
| November 30, 2017 | 0.2369 |
| August 31, 2017 | 0.2461 |
| May 31, 2017 | 0.2217 |
| February 28, 2017 | 0.2178 |
| November 30, 2016 | 0.2349 |
| August 31, 2016 | 0.2415 |
| May 31, 2016 | 0.2721 |
| February 29, 2016 | 0.2787 |
| November 30, 2015 | 0.2141 |
| August 31, 2015 | 0.1827 |
| May 31, 2015 | 0.1947 |
| February 28, 2015 | 0.2328 |
| November 30, 2014 | 0.2254 |
| August 31, 2014 | 0.1945 |
| May 31, 2014 | 0.1693 |
| February 28, 2014 | 0.1807 |
| November 30, 2013 | 0.2023 |
| August 31, 2013 | 0.2176 |
| May 31, 2013 | 0.2479 |
| February 28, 2013 | 0.2707 |
| November 30, 2012 | 0.3114 |
| August 31, 2012 | 0.3487 |
| May 31, 2012 | 0.3939 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-32.48
Minimum
Aug 2024
77.22
Maximum
Nov 2023
2.343
Average
0.8693
Median
Debt to Equity Ratio Benchmarks
| AngioDynamics Inc | 0.0244 |
| Precision Optics Corp Inc | 0.3155 |
| Sage Therapeutics Inc | 0.00 |
| Outset Medical Inc | 2.872 |
| NovaBay Pharmaceuticals Inc | -1.128 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 246.82M |
| Total Liabilities (Quarterly) | 250.76M |
| Shareholders Equity (Quarterly) | -3.938M |
| Current Ratio | 1.831 |
| Net Debt Paydown Yield | -3.88% |